title: Tibolone is not converted by human aromatase to 7alpha-methyl-17alpha-ethynylestradiol (7alpha-MEE): analyses with sensitive bioassays for estrogens and androgens and with LC-MSMS.
abstract: To exclude that aromatization plays a role in the estrogenic activity of tibolone, we studied the effect tibolone and metabolites on the aromatization of androstenedione and the aromatization of tibolone and its metabolites to 7alpha-methyl-17alpha-ethynylestradiol (7alpha-MEE) by human recombinant aromatase. Testosterone (T), 17alpha-methyltestosterone (MT), 19-nortestosterone (Nan), 7alpha-methyl-19-nortestosterone (MENT) and norethisterone (NET) were used as reference compounds. Sensitive in vitro bioassays with steroid receptors were used to monitor the generation of product and the reduction of substrate. LC-MSMS without derivatization was used for structural confirmation. A 10 times excess of tibolone and its metabolites did not inhibit the conversion of androstenedione to estrone by human recombinant aromatase as determined by estradiol receptor assay whereas T, MT, Nan, and MENT inhibited the conversion for 75, 53, 85 and 67%, respectively. Tibolone, 3alpha- and 3beta-hydroxytibolone were not converted by human aromatase whereas the estrogenic activity formed with the Delta4-isomer suggests a conversion rate of 0.2% after 120 min incubation. In contrast T, MT, Nan, and MENT were completely converted to their A-ring aromates within 15 min while NET could not be aromatized. Aromatization of T, MT, Nan and MENT was confirmed with LC-MSMS. Structure/function analysis indicated that the 17alpha-ethynyl-group prevents aromatization of (19-nor)steroids while 7alpha-methyl substitution had no effect. Our results with the sensitive estradiol receptor assays show that in contrast to reference compounds tibolone and its metabolites are not aromatized.
authors.affiliation: N.V. Organon, Research & Development Laboratories, Molenstraat 110, PO Box 20, 5340 BH, Oss, The Netherlands. marcel.degooyer@organon.com
authors.forename: Marcel E
authors.initials: ME
authors.lastname: de Gooyer
authors.forename: Hendrika M
authors.initials: HM
authors.lastname: Oppers-Tiemissen
authors.forename: Dirk
authors.initials: D
authors.lastname: Leysen
authors.forename: Herman A M
authors.initials: HA
authors.lastname: Verheul
authors.forename: Helenius J
authors.initials: HJ
authors.lastname: Kloosterboer
mesh_terms: D000728:Androgens / Q000378:metabolism; D000818:Animals; D001141:Aromatase / Q000378:metabolism*; D047072:Aromatase Inhibitors; D016466:CHO Cells; D002460:Cell Line; D002853:Chromatography, Liquid / Q000379:methods; D006224:Cricetinae; D004997:Ethinyl Estradiol / Q000031:analogs & derivatives* / Q000378:metabolism*; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D013058:Mass Spectrometry / Q000379:methods; D009652:Norpregnenes / Q000378:metabolism*; D043803:Phenalenes / Q000494:pharmacology; D013379:Substrate Specificity; D013997:Time Factors
chemical_list: C475050:7alpha-methyl-17alpha-ethynylestradiol; D000728:Androgens; D047072:Aromatase Inhibitors; D007093:Imidazoles; D009652:Norpregnenes; D043803:Phenalenes; C080905:Org 33201; D004997:Ethinyl Estradiol; D001141:Aromatase; C027385:tibolone